Schizophrenia

Videos

Effective Communication Strategies to Implement LAIs Into Treatment Plans

08/04/2021

In this video, Sanjai Rao, MD, DFAPA, shares effective communications strategies for clinicians to implement long-acting injectables (LAIs) in their patients’ treatment plans.

In this video, Sanjai Rao, MD,...

08/04/2021

Psych Congress Network

Videos

LAIs Offer Opportunity for Increased Medication Adherence in Patients With Schizophrenia

06/30/2021

Sanjai Rao, MD, DFAPA, suggests long-acting injectables (LAIs) offer a treatment plan that leads to a greater opportunity for adherence in patients with schizophrenia over daily medications.

Sanjai Rao, MD, DFAPA, suggests...

06/30/2021

Psych Congress Network

News

Reduced Antipsychotic Doses During Schizophrenia Maintenance Increase Relapse Risk

06/29/2021

Lowering an antipsychotic dose below the standard range recommended for acute stabilization appears to increase relapse risk and all-cause discontinuation during maintenance treatment in multi-episode schizophrenia.

Lowering an antipsychotic dose...

06/29/2021

Psych Congress Network

News

Anticholinergic Medication Associated With Cognitive Impairment in Patients With Schizophrenia

06/23/2021

Cognitive impairments are associated with commonly prescribed psychotropic medications with anticholinergic properties for patients with schizophrenia, according to new research.

Cognitive impairments are...

06/23/2021

Psych Congress Network

Videos

How to Improve Medication Adherence Rates Among Patients With Schizophrenia

06/14/2021

Jacob Ballon, MD, MPH, discusses why patients do not adhere to their medication treatment and tips for clinicians to improve medication adherence rates, in this expansion on his recent Psych Congress Elevate session.

Jacob Ballon, MD, MPH, discusses...

06/14/2021

Psych Congress Network

Videos

Best Practices for Matching Patients With Effective Antipsychotics and Mitigating Adverse Effects

06/08/2021

Jacob Ballon, MD, MPH, discusses key best practices for matching patients with schizophrenia with an effective antipsychotic, why patients do not adhere to their medication treatment, and mitigating adverse effects.

Jacob Ballon, MD, MPH, discusses...

06/08/2021

Psych Congress Network

Quiz

Rare Genetic Biomarker May Indicate Which Mental Health Disorder?

05/25/2021

Take the quiz: Researchers recently identified a single letter change in the DNA code in a gene called PCHA3 that is associated with which mental health disorder?

Take the quiz: Researchers...

05/25/2021

Psych Congress Network

Quiz

Rare Genetic Biomarker May Indicate Which Mental Health Disorder?

05/25/2021

Take the quiz: Researchers recently identified a single letter change in the DNA code in a gene called PCHA3 that is associated with which mental health disorder?

Take the quiz: Researchers...

05/25/2021

Psych Congress Network

News

Oral Dissolving Film Rapidly Eases Acute Agitation in Patients with Schizophrenia

05/11/2021

An oral dissolving film for sublingual or buccal administration of dexmedetomidine was effective and well-tolerated for the rapid treatment of acute agitation in patients with schizophrenia, according to a poster presented at the 2021 APA...

An oral dissolving film for...

05/11/2021

Psych Congress Network

Quiz

Percentage of Studied Population With Genetic Variant Linked to Schizophrenia

05/05/2021

Test your knowledge: Researchers recently identified a single letter change in the gene procadherin alpha 3 (PCDHA3) could result in early onset, treatment resistant schizophrenia. What percent of the Ashkenazi Jewish population studied had...

Test your knowledge: Researchers...

05/05/2021

Psych Congress Network